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Abstract
Background: Preoperative weight loss and abnormal serum-albumin have traditionally been associated with
reduced survival. More recently, a correlation between postoperative complications and reduced long-term survival
has been reported and the significance of the relative proportion of skeletal muscle, visceral and subcutaneous
adipose tissue has been examined with conflicting results. We investigated how preoperative body composition
and major non-fatal complications related to overall survival and compared this to established predictors in a large
cohort undergoing upper abdominal surgery.
Methods: From 2001 to 2006, 447 patients were included in a Norwegian multicenter randomized controlled trial
in major upper abdominal surgery. Patients were now, six years later, analyzed as a single prospective cohort and
overall survival was retrieved from the National Population Registry. Body composition indices were calculated from
CT images taken within three months preoperatively.
Results: Preoperative serum-albumin <35 g/l (HR = 1.52, p = 0 .014) and weight loss >5 % (HR = 1.38, p = 0.023)
were independently associated with reduced survival. There was no association between any of the preoperative
body composition indices and reduced survival.
Major postoperative complications were independently associated with reduced survival but only as long as
patients who died within 90 days were included in the analysis.
Conclusions: Our study has confirmed the robust significance of the traditional indicators, preoperative serum-albumin
and weight loss. The body composition indices did not prove beneficial as global indicators of poor prognosis in upper
abdominal surgery. We found no association between non-fatal postoperative complications and long-term survival.
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Background
Preoperative weight loss and abnormal serum-albumin
have been associated with unfavorable postoperative out-
come for more than a decade [1–3]. An involuntary
weight loss of five percent or more has been recognized
to be associated with reduced survival for more than
thirty years and it has been proposed as a diagnostic cri-
terion for cancer cachexia [4–6].
Sarcopenia (i.e. loss of skeletal muscle) has been
shown to be associated with reduced survival after can-
cer surgery [7–9]. Sarcopenia has also been associated
with postoperative complications [10], increased chemo-
therapy toxicity and decreased time to tumor progression
[11]. While visceral adiposity has been associated with dia-
betes, and diabetes again has been associated with un-
favorable outcome after surgery; evaluations of a direct
association between adipose tissue indices and unfavorable
outcome have shown conflicting results [9, 12, 13].
An association between major postoperative complica-
tions and reduced long-term survival has been shown
for a wide range of malignant and non-malignant dis-
eases [14–19]. Khuri et al. reported such association
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even when those who die within 30 days after surgery
were excluded from analysis and it has been suggested
that complications could alter the immune system and
make patients more susceptible to cancer recurrence
[14, 15]. In light of improved, modern intensive care
medicine we suspect that a 30 day cut-off might not cor-
rectly identify those who die as a direct result of their
complication. It is not known whether there is an associ-
ation between complications and long-term survival in
major upper abdominal surgery when only those who
survive more than 90 days after surgery are analyzed.
We aimed to investigate the association between pre-
operative body composition indices, weight loss and
serum-albumin, postoperative complications and overall
survival after major upper abdominal surgery.
Methods
From 2001 to 2006, 447 patients were included in a Nor-
wegian multicenter randomized controlled trial (RCT),
which investigated normal food at will after major upper
gastrointestinal (GI) and hepatopancreatobiliary (HPB)
surgery [20]. Further analysis has not been performed on
this dataset and it was treated here as a single, prospective
cohort. We retrieved survival data from the Norwegian
Population Registry during April 2012, six years after the
last patient was included in the original trial.
In addition to demographics and general clinical char-
acteristics, the prospective database included specifically:
patient-reported preoperative weight loss, preoperative
serum-albumin, type of surgery and major postoperative
complications. Major complications, within eight weeks
after surgery where defined a priori in the original trial
[20] (Table 1). The operative procedures were listed in
the original publication [20].
Preoperative weight loss was calculated from patients’
usual pre-morbid weight as they reported it - with no
time limit, and current weight as scaled preoperatively
at trial enrolment. We used well-established cut-offs for
preoperative weight loss and serum-albumin [6, 21].
Preoperative weight loss was dichotomized into >5 % or
≤5 %. Preoperative serum-albumin was dichotomized
into <35.0 g/l or ≥35.0 g/l. Body Mass Index, BMI was
calculated with the following formula [22]: BMI =
weight (kg)/height2 (m).
Digitally stored computer tomography (CT) images for
initial routine diagnostics and staging were analyzed using
Slice-O-Matic software V4.2 (Tomovision, Montreal-
Canada) which permitted specific tissue demarcation
using Houndsfield unit threshold of −29 to +150 for skel-
etal muscles [23], −150 to −50 for visceral adipose tissue
[24], and −190 to −30 for subcutaneous adipose tissue
[23]. Cross-sectional areas (cm2) were calculated for each
tissue by summing tissue pixels and multiplying by the
pixel surface area. A transverse CT image from the third
lumbar vertebrae (L3) was assessed for each scan and tis-
sue areas estimated [25]. All CT images were analyzed by
one single trained observer who was blinded to all clinical
data. Cross-sectional area was normalized for stature
(cm2/m2) and the following indices were calculated: L3
Skeletal muscle index (L3 SMI), L3 Visceral adipose tissue
index (L3 VAT) and L3 Subcutaneous adipose tissue index
(L3 SAT). CT images used for analysis were retrieved from
routine images done within three months preoperatively.
We used the cut-off for L3 SMI suggested by Martin
et al. [26]: L3 SMI <41 cm2/m2 for women, L3 SMI
<43 cm2/m2 for men with BMI <25 kg/m2 and L3 SMI
<53 cm2/m2 for men with BMI ≥25 kg/m2. We also cal-
culated the percentage of women and men with L3 SMI
lower than the cut-offs suggested by Mourtzakis et al.
and later used in a consensus article on cachexia and
sarcopenia [6, 27], which corresponds to skeletal muscle
mass two standard deviations from that of healthy
young adults (39 cm2/m2 for women and 55 cm2/m2 for
men). Preoperative weight loss, serum-albumin and L3
SMI were analyzed both as dichotomous and continu-
ous variables. L3 VAT and L3 SAT were analyzed only
as continuous variables.
All patients with complete data sets for preoperative
serum-albumin and weight loss were included in ana-
lysis. A subgroup analysis was performed on patients
with available preoperative CT images. Patients were di-
vided into the following disease-categories: Gastroesoph-
ageal cancer, pancreatic cancer, other cancer (mainly
malignant liver tumors and colorectal liver metastasis)
and non-cancer.
Statistics
Statistical analysis was performed with SPSS statistics
software, version 22 (IBM, New York -USA). A Cox pro-
portional hazard regression analysis, stratified for
disease-categories, was used for analysis of overall sur-
vival; the assumption of proportional hazards was visually
inspected by log-log survival curves. For comparison of
characteristics between different groups and categories,
analysis of variance (ANOVA) for continuous data and
Pearson chi-square test for categorical data were used.
Kruskal-Wallis test and Mann–Whitney U test were used




There were 447 patients included in the original trial.
Survival data were obtained for 438 patients (98.0 %).
Complete information on preoperative weight loss and
serum-albumin was available for 369 patients (82.5 %).
Preoperative CT images of sufficient quality were avail-
able in 157 of these patients (157/369 = 42.5 %). There
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were no significant differences in complication rates or
overall survival between patients included (n = 369) and
those excluded due to missing nutritional data (n = 69).
There were no significant differences in complication
rates or overall survival between patients with available
CT images (n = 157) and patients without available CT
images (n = 212). Of the 369 patients available for ana-
lysis, 26 patients (7.0 %) had died within 90 days. The
five year mortality rates varied between 20.4 % in pa-
tients without cancer and 77.6 % in patients with pan-
creatic cancer (Table 2).
Preoperative weight loss, serum-albumin and body
composition
Median preoperative weight loss was 1.8 % (not nor-
mally distributed). There were 131 patients with pre-
operative weight loss >5 % (35.6 %) while 175 patients
had no preoperative weight loss (47.4 %). Mean serum-
albumin concentration was 39.0 g/l. The number of pa-
tients with serum-albumin <35 g/l was 62 (16.8 %).
Five-year mortality spanned from 44.6 % in patients
with no preoperative weight loss to 67.8 % in patients
with >10 % preoperative weight loss (Table 3). There
were no statistically significant differences in L3 SMI be-
tween different preoperative weight loss categories
(Table 3).
Mean L3 SMI was 41.8 cm2/m2 in women and
47.0 cm2/m2 in men. Of the 157 patients with L3 SMI
analyzed, 72 (45.9 %) had L3 SMI below Martin's cut-off
[26]. Only 7 (9.7 %) of these patients were obese. The
proportion of women and men with L3 SMI below
Martin’s cut-off were 47.5 % and 44.8 % respectively.
The number of patients with L3 SMI below Mourtzakis’s
cut-off [27] was 110 (70.1 %). Only 6 (5.5 %) of these pa-
tients were obese. The proportion of women and men
with L3 SMI below Mourtzakis’s cut-off were 37.7 % and
90.6 % respectively (Fig. 1).
Table 1 Major postoperative complications: definition and criteria
Complication Criteria
SIRS Two or more of the following:
Temperature >38 °C or <36 °C
Heart rate >90 beats/min
Respiratory rate >20/min or PaCO2 < 4,3kPa
White blood cell count >12000 cell/ml or
<4000 cells/ml or >10 % immature forms
Bacteraemia At least one positive blood culture of pathogenic organisms
Sepsis SIRS + bacteraemia
Pneumonia X-ray confirmed and necessitating antibiotic treatment
Anastomotic leak Necessitating re-operation or demonstrated upon autopsy
Bowel obstruction, necrosis or perforation Necessitating re-operation or demonstrated upon autopsy
Intra abdominal abscess Necessitating re-operation or percutaneous drainage or demonstrated upon autopsy
Intra abdominal haemorrhage Necessitating re-operation, transfusion of six or more units of Packed Red Blood Cells within
first 48 h postop. or demonstrated upon autopsy
Wound rupture Necessitating re-suturing in general anesthesia or demonstrated upon autopsy
Pancreatitis Serum enzyme level twice upper normal value, absence of known pre-existing pancreatitis, ERCP or
mechanical trauma to pancreas during operation providing satisfactory explanation for elevated enzymes
Cholecystitis Confirmed by histological examination of specimen or by cultured content from percutaneous drainage
Myocardial infarction Diagnostic enzyme pattern and either typical pain or ECG changes, or demonstrated upon autopsy
Myocardial arrhythmia ECG confirmed, with hypotension or symptomatic angina, necessitating stabilizing drugs or electro-conversion
Cardiac arrest Confirmed by ECG or cardiac rhythm monitoring, and necessitating resuscitation
Acute Cardiac failure Confirmed by by Echocardiosonography or necessitating pressure agents
Cerebrovascular infarction or
cerebrovascular haemorrhage
New, and persistent (>48 h) central neurological deficit, and confirmed by CT scan or demonstrated upon autopsy
Pulmonary embolism Confirmed by unequivocal nuclear isotope scan, ECG, pulmonary angiography, spiral technique CT scan
or demonstrated upon autopsy
Pulmonary insufficiency Necessitating postoperative ventilation support more than 24 h
Major postoperative complications as defined in the original randomized trial [20]
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A significant difference in BMI and age by quartile cat-
egories of L3 SMI was observed (Table 4). However, no
significant differences in complication rates or five-year
mortality between the different quartile categories of L3
SMI were found, nor did we demonstrate any differences
in mean preoperative weight loss or serum-albumin
(Table 4).
Complications
Major postoperative complications were suffered by 115
(31.2 %) patients. The only variable that differed signifi-
cantly between patients with and without major postop-
erative complications was serum-albumin concentration
(p = 0.016). Odds ratio for major postoperative complica-
tions with preoperative serum-albumin <35 g/l was 2.08
(p = 0.010). There were no significant association be-
tween preoperative weight loss and major postoperative
complications (p = 0.688).
Overall survival
Preoperative weight loss >5 % (HR = 1.38, p = 0.023) and
preoperative serum-albumin <35 g/l (HR = 1.52, p = 0
.014) were independently associated with reduced overall
survival (Table 5). Experiencing a major postoperative
complication was independently associated with reduced
overall survival (HR = 1.51, p = 0.003), but not when pa-
tients who died within 90 days after surgery were ex-
cluded from analysis (p = 0.133) (Table 5).
L3 SMI below Martin’s cut-off values [26] were associ-
ated with statistically significant improved overall sur-
vival in the unadjusted analysis (HR = 0.66, p = 0.037),
but this significance did not remain in the multivariable
adjusted analysis (HR = 0.69, p = 0.066) (Table 5). Similar
results were seen after exclusion of patients without can-
cer, in both the unadjusted (HR = 0.60, p = 0.014) and
multivariable adjusted (HR = 0.62, p = 0.026) analysis.
There was no significant association between L3 SMI,
L3 VAT or L3 SAT and changes in overall survival
(Table 5). Preoperative weight loss and serum-albumin,
when analyzed as continuous variables in the same sub-
group, were independently associated with statistically
significant changes in overall survival.
Discussion
The main aim of our investigation was to explore the
novel field of CT-based preoperative body composition
indices and compare with traditional indicators for poor
prognosis and to explore the significance of non-fatal
major postoperative complications. We have shown a
significant association between both preoperative weight
loss >5 % and serum-albumin <35 g/l and reduced overall
survival in a large cohort of patients undergoing major
upper abdominal surgery. Conversely, there was no associ-
ation between L3 skeletal muscle index, L3 visceral adi-
pose tissue index or L3 subcutaneous adipose tissue index,
and overall survival. We found an association between
major postoperative complications and reduced overall
survival, but not when patients who died within 90 days
after surgery were excluded from analysis.
The relationship between patient-reported preopera-
tive weight loss and adverse outcome has been known
since Hiram Studley’s 1936 publication on mortality after
surgery for chronic peptic ulcer patients [4]. The rela-
tionship between abnormal serum-albumin and adverse
outcome is well documented [2, 3]. Our study has again
Table 2 Disease categories: characteristics, postoperative complications and 5-year mortality
Gastroesophageal cancer Pancreatic cancer 0ther cancer Non cancer P-
value(n = 122) (n = 85) (n = 64) (n = 98)
Age, mean (SD) 68 (13) 64 (10) 63 (13) 60 (15) <0.001
Male gender, n (%) 75 (61.4 %) 58 (68.2 %) 36 (56.3 %) 50 (51.0 %) 0.108
Complicationsa, n (%) 45 (36.9 %) 27 (31.8 %) 21 (32.8 %) 22 (22.4 %) 0.143
5-year mortality, n (%) 79 (64.8 %) 66 (77.6 %) 35 (54.7 %) 20 (20.4 %) <0.001
a) Major postoperative complications within eight weeks after surgery
Table 3 Categories of preoperative weight loss: characteristics, complications and 5-year mortality
No weight loss 1-5 % weight loss 6-10 % weight loss >10 % weight loss P-
value(n = 175) (n = 63) (n = 72) (n = 59)
Serum-albumin (g/l), mean (SD) 40.3 (5.6) 38.4 (5.6) 38.1 (4.4) 36.9 (5.4) <0.001
L3 SMI, mean (SD)a 45.6 (7.3) 43.1 (5.5) 46.6 (5.6) 43.0 (6.1) 0.071
Complicationsb 51 (29.1 %) 21 (33.3 %) 25 (34.7 %) 18 (30.5 %) 0.823
5-year mortality, n (%) 78 (44.6 %) 37 (58.7 %) 45 (62.5 %) 40 (67.8 %) 0.004
a) Calculated for patients with available preoperative CT images only (n = 157)
b) Major postoperative complications within eight weeks after surgery
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confirmed the robust significance of these easily avail-
able indicators.
CT-based body composition indices constitute a novel
field. Two methods for calculating skeletal muscle area
have emerged in the recent years: the measurement of
the total psoas muscle area and the combined skeletal
muscle area on a transverse CT image at the third lum-
bar vertebrae level [27, 28]. Several different cut-off
values for L3 skeletal muscle index (L3 SMI) to define
sarcopenia have been suggested, some of them are
almost identical. Mourtzakis et al. suggested cut-offs,
corresponding to skeletal muscle mass as measured on
dual energy x-ray absorptiometry, to be two standard
deviations below that of healthy young adults [27]. These
cut-offs, 39 cm2/m2 for women and 55 cm2/m2 for men,
were later used in a consensus document on cancer cach-
exia [6]. Prado et al. suggested cut-offs in sarcopenic-
obese patients at 38.5 cm2/m2 for women and 52.4 cm2/
m2 for men [29]. Van Vledder et al. suggested cut-offs in
patients with colorectal liver metastasis: 41.1 cm2/m2 for
women and 43.75 cm2/m2 for men [8]. Based on a large
cohort of patients with gastrointestinal and lung cancers,
Martin et al. developed cut-offs according to Body Mass
Index [26]: 41 cm2/m2 for women, 43 cm2/m2 and
53 cm2/m2 for men with BMI under or over 25 kg/m2
respectively.
Fig. 1 Distribution of L3 skeletal muscle index
Table 4 Quartile categories of L3 Skeletal muscle index: characteristics, complications and 5-year mortality








(cm2/m2) = W: 45.6-58.7
M: 33.2-43.5 M: 43.7-47.0 M: 47.3-50.1 M: 50.2-62.2
Age, mean (SD) 67 (12) 65 (11) 59 (12) 62 (12) 0.024
BMI (kg/m2), mean (SD) 22.9 (3.5) 24.2 (3.7) 24.9 (3.9) 27.7 (4.8) <0.001
Weight loss (%), mean (SD) 6.0 (6.6) 5.2 (6.2) 5.2 (6.4) 2.7 (5.0) 0.001
Serum-albumin (g/l), mean (SD) 39.9 (7.4) 39.0 (4.0) 39.8 (7.1) 39.5 (5.2) 0.911
Complicationsa, n (%) 12 (30.8 %) 18 (46.2 %) 12 (33.3 %) 12 (27.9 %) 0.329
5-year mortality, n (%) 22 (56.4 %) 25 (64.1 %) 25 (69.4 %) 22 (51.2 %) 0.360
W women, M men
a) Major postoperative complications within eight weeks after surgery
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We used the cut-offs suggested by Martin et al. and
found a significant association between sarcopenia and
improved overall survival in the unadjusted analysis, but
not in the multivariable adjusted analysis. We find it un-
likely that sarcopenic patients have improved overall sur-
vival following major upper abdominal surgery. There
was no significant association when L3 Skeletal muscle
index was analyzed as a continuous variable, nor was
there any difference in five-year mortality between the
different quartile categories of L3 SMI index. We suggest
that this exemplifies the known hazards of using a dichot-
omous variable in a heterogeneous cohort of patients [30].
We have indeed presented preoperative weight loss and
serum-albumin as dichotomous variables, but the associ-
ation between these variables and overall survival was con-
firmed when analyzed as continuous variables. No cut-off
values were applied when analyzing L3 VAT and L3 SAT
indices. There was no association between these continu-
ous variables and survival and to our knowledge, no cut-
off values are established.
The lack of association between the tissue indices ana-
lyzed in our study and outcome might indicate that
these indices do not necessarily mirror a disease-related
catabolic process. Instead, they may provide only a spot
measurement of body composition with a large normal
variance. In a study with a relatively small number of pa-
tients, Awad et al. reported a significant loss of skeletal
muscle tissue in a esophagogastric cancer patients who
received neoadjuvant chemotherapy, but no association
between such tissue loss and clinical outcomes [31]. The
potential association between ongoing loss of skeletal
muscle tissue, i.e. a catabolic process, and outcomes
should be explored further.
An association between sarcopenia and survival in
specific patient categories, like primary liver cancer pa-
tients or sarcopenic-obese patients has been reported
[7, 9, 29]. Tissue indices might be particularly important
in these categories, but the number of patients with
these characteristics in our study was too small for any
meaningful analysis.
The association between sarcopenia and survival may
not be equal in all diseases or even in different stages of
the same disease. Del et al. reported more complete
pathological response and longer progression free sur-
vival in sarcopenic, compared to non-sarcopenic, pa-
tients with operable breast cancer who received
neoadjuvant chemotherapy [32]. Prado et al. reported
increased chemotherapy toxicity and shorter time to
tumor progression in sarcopenic, compared, to non-
sarcopenic patients with metastatic breast cancer who
received Capecitabine [11]. Body composition indices
might be important when patients receive chemothera-
peutic agents that are unevenly distributed in the dif-
ferent body compartments. The reasons behind a low
skeletal muscle index might also differ depending on
cancer stage and development.
Table 5 Predictors of overall survival, stratified (on disease-categories) analysis
Risk factors, complications and overall survival
Unadjusted Multivariable adjusted
HR 95 % CI P-value HR 95 % CI P-value
Age >65 years 1.29 0.99-1.68 0.058 1.21 0.92-1.58 0.173
Male gender 1.11 0.85-1.45 0.456 1.02 0.78-1.34 0.873
Weight loss >5 % 1.48 1.12-1.94 0.005 1.38 1.04-1.83 0.023
Serum-albumin <35 g/l 1.80 1.30-2.49 <0.001 1.52 1.09-2.14 0.014
Complications 1.58 1.21-2.06 0.001 1.51 1.15-1.98 0.003
Complications and overall survival excluding patients alive <90 daysa
Complications 1.30 0.97-1.75 0.075 1.25 0.93-1.69 0.133
Sarcopenia and overall survivalb
Sarcopenia 0.66 0.45-0.98 0.037 0.69 0.46-1.03 0.066
Weight loss, serum-albumin and tissue indices, analyzed as continuous variables, and overall survivalc
Weight loss (%) 1.05 1.02-1.08 0.002 1.05 1.01-1.09 0.010
Serum-albumin (g/l) 0.97 0.94-0.99 0.018 0.96 0.93-0.99 0.020
L3 SMI (cm2/m2) 1.02 0.99-1.05 0.301 1.00 0.96-1.04 0.914
L3 VAT (cm2/m2) 1.00 1.00-1.01 0.491 1.00 0.99-1.01 0.426
L3 SAT (cm2/m2) 1.00 0.99-1.01 0.657 1.00 0.99-1.01 0.897
a) Major postoperative complications within eight weeks after surgery. Adjusted for age >65 years, gender, weight loss >5 % and serum-albumin <35 g/l in the
multivariable adjusted analysis
b)Patients with available preoperative CT images (n = 157). L3 SMI <41 cm2/m2 for women. L3 SMI <43 cm2/m2 for men with BMI <25 kg/m2 and L3 SMI <53 cm2/m2 for
men with BMI ≥25 kg/m2. Adjusted for age >65 years, gender, weight loss >5 % and serum-albumin <35 g/l in the multivariable adjusted analysis
c) Patients with available preoperative CT images (n = 157). Age >65 years and gender is also included in the multivariable adjusted analysis
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Major postoperative complications have been associ-
ated with reduced survival for patients surgically treated
for malignant or non-malignant diseases [14–19]. Non-
fatal complications (excluding patients who die within
30 days after surgery) has also been linked to reduced
survival [14]. This has led to speculations concerning
an immune modulating effect of complications which
might make the patient more susceptible to cancer re-
currence [14, 15]. We extended the definition of fatal
complications to death within 90 days and found no
association between non-fatal complications and re-
duced survival. Major postoperative complications may
preclude or delay administration of adjuvant chemo-
therapy [17]. Both the administration and the benefit
of adjuvant chemotherapy is diverse in heterogenic
upper GI and HPB patient groups like ours and this
may also explain why we could not find any association
between complications and survival.
Our cohort consisted of patients enrolled in a na-
tional multicenter clinical trial [20]. This trial investi-
gated the safety of food at will after all kinds of major
upper abdominal surgery [20]. Using this cohort, with-
out further selection of patients, gave us the opportun-
ity to investigate both old and novel indicators of poor
prognosis in a clinical setting and to do so prospect-
ively with long observation time.
Our study has several weaknesses: We lacked infor-
mation about cancer-stage, and the number of patients
with available CT-images of sufficient quality was rela-
tively small. The patients in our cohort have not been
controlled in a homogeneous follow-up program, so
cause of death and disease-specific survival would be
unreliable. Despite these weaknesses, our study adds
important knowledge: While preoperative weight loss
and abnormal serum-albumin were associated with re-
duced survival independent of disease-categories, the
opposite pattern was shown with the body composition
indices. Cancer-stage is an important confounder,
probably linked to both weight loss and serum-
albumin. Exact information about cancer-stage is gen-
erally not available in a preoperative setting, which
make global indicators, like preoperative weight loss
and serum-albumin, important in recognizing ad-
vanced disease.
Conclusion
Our study adds to the core knowledge of preoperative
weight loss and abnormal preoperative serum-albumin
as important preoperative indicators of poor prognosis.
These tools are independent of age, gender, and disease
category in upper abdominal surgery. Body compos-
ition indices, as defined and utilized in the present
study, did not provide additional information of clin-
ical importance. We did not find any evidence of an
association between non-fatal complications and long-
term survival in major upper abdominal surgery.
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